Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 189,796 |
|
|||||
| News | (1) | ||||||
| Day High | 15.1275 | Low High |
|||||
| Day Low | 14.355 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Y mAbs Therapeutics Inc | YMAB | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.13 | -0.88% | 14.71 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 14.92 | 14.355 | 15.1275 | 14.71 | 14.84 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,738 | 189,796 | US$ 14.63 | US$ 2,775,792 | - | 4.60 - 20.90 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:05:54 | 50 | US$ 14.85 | USD |
Y mAbs Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 642.65M | 43.78M | - | 84.82M | -21.43M | -0.49 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Y mAbs Therapeutics News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical YMAB Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 14.85 | 16.39 | 14.28 | 15.15 | 395,353 | -0.14 | -0.94% |
| 1 Month | 16.36 | 17.49 | 13.34 | 14.93 | 364,704 | -1.65 | -10.09% |
| 3 Months | 13.19 | 20.90 | 11.7001 | 15.46 | 388,784 | 1.52 | 11.52% |
| 6 Months | 5.35 | 20.90 | 4.69 | 12.10 | 330,458 | 9.36 | 174.95% |
| 1 Year | 5.76 | 20.90 | 4.60 | 9.93 | 288,160 | 8.95 | 155.38% |
| 3 Years | 27.97 | 39.8199 | 2.70 | 11.34 | 400,785 | -13.26 | -47.41% |
| 5 Years | 23.55 | 55.36 | 2.70 | 17.48 | 326,759 | -8.84 | -37.54% |
Y mAbs Therapeutics Description
| Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. Its pipeline covers Naxitamab, Omburtamab, GD2-GD3 Vaccine, and others. |
